Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Moran Michael Shawn Create: Alert

All | News | Filings
Date FiledTypeDescription
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 742 shares @ $45.03, valued at $33.4k
02/01/2022 4 Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 210 shares @ $45.94, valued at $9.6k
01/11/2022 4 Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 90 shares @ $50.63, valued at $4.6k
01/07/2022 4 Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 1,511 shares @ $50.69, valued at $76.6k
10/07/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy